Clinical Trials Browser

Daclizumab × Lymphoid × Clear all

NCT00006350 2019-11-04

Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

NCT00019227 2013-06-20

Monoclonal Antibody Therapy in Treating Patients With Leukemia

Phase 1/2 Completed

LymphoidOther hematologic neoplasm

Lymphoma, Radiation Injuries, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00001941 2012-08-20

Anti-Tac for Treatment of Leukemia

Phase 1/2 Completed

34 enrolled 12 charts

LymphoidOther hematologic neoplasm

Diabetes Mellitus, Insulin-Dependent, 10, Leukemia, T-Cell, Leukemia-Lymphoma, Adult T-Cell, HTLV-I Infections

NCT00002681 2011-06-10

Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma

Phase 1/2 Completed

25 enrolled

LymphoidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative